Advertisement
U.S. markets closed

Bliss GVS Pharma Limited (BLISSGVS.NS)

NSE - NSE Real Time Price. Currency in INR
124.61-7.12 (-5.40%)
At close: 03:30PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 13.92B
Enterprise Value 13.51B
Trailing P/E 17.20
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.77
Price/Book (mrq)1.43
Enterprise Value/Revenue 1.71
Enterprise Value/EBITDA 8.55

Trading Information

Stock Price History

Beta (5Y Monthly) 0.96
52-Week Change 360.45%
S&P500 52-Week Change 337.82%
52 Week High 3149.60
52 Week Low 377.35
50-Day Moving Average 3127.75
200-Day Moving Average 3117.43

Share Statistics

Avg Vol (3 month) 31.13M
Avg Vol (10 day) 3845.24k
Shares Outstanding 5105.3M
Implied Shares Outstanding 6105.64M
Float 840.4M
% Held by Insiders 162.32%
% Held by Institutions 16.94%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.5
Forward Annual Dividend Yield 40.38%
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 40.57
Payout Ratio 46.53%
Dividend Date 3N/A
Ex-Dividend Date 4Jul 19, 2024
Last Split Factor 28:5
Last Split Date 3Sep 26, 2008

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 10.26%
Operating Margin (ttm)14.97%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)7.94B
Revenue Per Share (ttm)75.99
Quarterly Revenue Growth (yoy)15.10%
Gross Profit (ttm)N/A
EBITDA 1.59B
Net Income Avi to Common (ttm)814.66M
Diluted EPS (ttm)7.65
Quarterly Earnings Growth (yoy)40.90%

Balance Sheet

Total Cash (mrq)1.4B
Total Cash Per Share (mrq)13.41
Total Debt (mrq)998.4M
Total Debt/Equity (mrq)9.95%
Current Ratio (mrq)N/A
Book Value Per Share (mrq)92.39

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A